Global Life Science Tools in Healthcare Market Assessment, By Type [Instruments, Consumables, Services], By Technology [Genomics, Proteomics, Cell Biology Technology, Lab Supplies, and Others], By Product [Liquid Chromatography, Mass Spectrometry, Liquid Chromatography, Flow cytometry, and Others], By End-user [Healthcare, Government & Academic Institutions, Biopharmaceutical Companies, Industrial Applications, and Others], By Region [North America, Europe, Asia Pacific, South America, Middle East and Africa], Opportunities and Forecast, 2016-2030F

Global Life Science Tools market size was valued at USD 151.28 billion in 2022 which is expected to reach USD 315.66 billion in 2030 with a CAGR of 9.63% for the forecast period between 2023 and 2030.

Home>Industry Reports>Global Life Science Tools in Healthcare Market Assessment, Opportunities and Forecast, 2016-2030F

Global Life Science Tools market size was valued at USD 151.28 billion in 2022 which is expected to reach USD 315.66 billion in 2030 with a CAGR of 9.63% for the forecast period between 2023 and 2030. The rapid development of life sciences tools and technologies such as gene sequencing, mass spectroscopy, chromatography, nuclear magnetic resonance (NMR), and other varied goods is contributing to innovation.

Additionally, the market is being driven by factors such as increasing investments by biopharmaceutical companies for the creation of advanced therapies, increasing need for novel medicines and treatments, rapid adoption of instruments such as flow cytometers, spectrometers, microscopes, chromatography columns, nucleic acid processing equipment and increasing prevalence of chronic diseases such as cancer, diabetes, thyroid disorders and many others.

The development of molecular diagnostic techniques such as digital droplet PCR, next-generation sequencing (NGS), and genome-wide sequencing has led to the introduction of DNA testing in clinical settings. For instance, Illumina, a global leader in DNA sequencing, and Genoscreen, a genomics company announced their partnership in October 2022 to speed up ending tuberculosis globally. This collaboration aims to enhance resources and skills in nations greatly affected by tuberculosis, such as India, to improve the efficiency of identifying and fighting against multidrug-resistant TB.

Increasing Demand for Biopharmaceuticals

The growing need for biologics, which often utilize recombinant DNA technology, is expected to fuel the expansion of the life science tools market. Biopharmaceuticals offer advantages such as increased efficacy, reduced adverse effects, minimized risk of drug interactions and improved patient outcomes. To meet the increasing demand and enhance the production of biological treatments, the life science industry is currently focusing on advanced analytical models such as predictive analytics. These cutting-edge innovations are being facilitated by significant technological improvements such as laboratory upgrades, strategic advancements, and operational optimizations. The demand for biopharmaceutical products has increased due to their enhanced safety, effectiveness, and ability to cure previously untreatable medical conditions.

Rapid Technological Advancements

Technological advancements have led to the growing utilization of various tools in the field, such as next sequencers, PCR (Polymerase Chain Reaction) and qPCR (quantitative polymerase chain reaction) machines, flow cytometers, spectrometers, microscopes, chromatography columns, nucleic acid processing equipment, and cell biology instruments. These advancements have had a significant impact on the integration of DNA assays in clinical settings, specifically in molecular diagnostic techniques like digital droplet PCR, NGS, and genome-wide sequencing. These methods have improved accuracy, timeframe, and reproducibility. To effectively harness the therapeutic potential of circulating nucleic acids, it is crucial to have an efficient extraction process.

Becton, Dickinson and Company (BD), a prominent global medical technology company, and Labcorp, a premier life sciences company, announced a strategic collaboration in August 2022. The collaboration aims to establish a framework for the development, production, marketing, and commercialization of companion diagnostics (CDx) based on flow cytometry. These CDx solutions are designed to complement the administration of potentially life-altering therapies for cancer and similar diseases.

Healthcare Sector is Experiencing Rapid Growth

The healthcare sector emerged as the leading contributor to the market value in 2022 and is expected to exhibit significant growth throughout the forecast period. This segment encompasses clinics, hospitals, community centers, diagnostic laboratories, and physician offices. The increasing adoption of proteomic and genomic workflows in hospitals for the diagnosis and treatment of various clinical abnormalities is predicted to drive market growth. The healthcare sector's expansion is primarily attributed to the extensive utilization and demand for tissue diagnostic solutions in hospitals. Clinicians are increasingly opting for tissue-based diagnostic tests over conventional methods due to their quick turnaround time. The integration of genomic sequencing in hospitals and clinical settings is predicted to improve patient care and reduce healthcare costs. This development is expected to drive the rapid growth of the healthcare sector. Furthermore, advancements in tools and equipment have significantly enhanced the accuracy of complex medical procedures in hospitals. The precision and reliability of medical diagnostic outcomes largely rely on the laboratory tools utilized for analysis, which positively impacts the expansion of the market.

For Instance, in January 2023, QIAGEN entered into an exclusive strategic agreement with Helix, a population genomics company based in California. According to the recently disclosed agreement, QIAGEN will have exclusive rights to market and handle contracts for Helix's companion diagnostic services within the United States. This collaboration will utilize the Helix Laboratory Platform, which has received the pioneering de novo class II authorization from the U.S. Food & Drug Administration for a comprehensive exome sequencing platform.

Growth of Cell and Gene Therapies is Propelling Market Growth

The utilization of genomic technologies on a global scale is on the rise, leading to advancements in diagnostic tests and procedures for various diseases and driving the growth of the market. A recent example is the commercial launch of a new molecular polymerase chain reaction (PCR) assay for the monkeypox virus by Becton, Dickinson, and Company (BD) and CerTest Biotec in September 2022, targeting both the United States and global markets. It is important to note that this PCR assay is currently intended for research purposes only. With the introduction of such innovative products, the market is expected to experience robust growth throughout the projected period. A comprehensive understanding of cell biology has emerged as an asset in laboratory workflows, creating new opportunities for market expansion. Furthermore, scientists in the life science field are keen to adopt cutting-edge instruments, which is anticipated to further strengthen this segment. Companies such as Cytiva, BioTek Instruments, Horizon Discovery, and Seahorse Bioscience are introducing instruments related to cell analysis, cell biology and imaging. The demand for tools and equipment is being propelled by the rising research and development activities conducted by prominent industrial companies.

A notable example is the strategic partnership between Haihe and EdiGene Laboratory, announced in January 2022, aimed at developing platform technologies and stem regenerative cell treatments. This collaboration focuses on exploring advanced biomarkers to enhance quality control in stem cell production.

Impact of COVID-19

The COVID-19 pandemic has had a significant impact on the life science tools industry and their respective supply chains worldwide. This disruption can be attributed to several factors, including the scarcity of raw materials and labor, as well as interruptions in the transportation of these materials across regions. As a result, there has been a shortage of critical medical supplies in different parts of the world, including molecular and immunoassay kits, digital solutions, life-support machines, and drugs. The COVID-19 pandemic had spurred a competitive race among manufacturers to create rapid diagnostics for the detection of SARS-CoV-2 virus, resulting in remarkable advancements and breakthroughs in terms of innovative solutions. These tests utilize various methods such as PCR for detecting the SARS-CoV-2 nucleic material, nucleic acid hybridization-related techniques, or serological and immunological assays for detecting antibodies produced in response to the virus.

For instance, in December 2021, Siemens Healthineers obtained emergency use authorization from the FDA for its ‘Clinitest’, a rapid COVID-19 antigen self-test, that can be self-administered by individuals aged 14 and above.

Global Life Science Tools Market: Report Scope

Global Life Science Tools Market Assessment, Opportunities and Forecast, 2016-2030F”, is a comprehensive report by Markets & Data, providing in-depth analysis and qualitative & quantitative assessment of the current state of the life science tools market globally, industry dynamics and challenges. The report includes market size, segmental shares, growth trends, COVID-19 impact, opportunities and forecast between 2023 and 2030. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.

 

Report Attribute

Details

Base Year of the Analysis

2022

Historical Period

2016-2021

Forecast Period

2023-2030

Projected Growth Rate

CAGR of 9.63% between 2023 and 2030

Revenue Forecast in 2030

USD 315.66 billion

Units

Revenue in USD billion

Segments Covered

Type, Technology, Product, End-user, and Region

Regions Covered

North America, Europe, Asia-Pacific, Middle East, and Africa, South America

Key Companies Profiled

Becton, Dickinson, and company, Agilent Technologies Inc, Illumina Inc., Thermo Fisher Scientific Inc., Merck KGaA, GE Healthcare, Bruker Corporation, Qiagen NV, Danaher Corporation, Abbott Laboratories Inc, Shimadzu Corporation, Hitachi, Ltd., Oxford Instruments plc, Zeiss International.

Customization Scope

15% free report customization with purchase

Pricing and Purchase Options

Avail the customized purchase options to fulfil your precise research needs

Delivery Format

PDF and Excel through email (subject to the license purchased)

 

In this report, Global Life Science Tools Market has been segmented into the following categories: 

1.       By Type

1.1.   Instruments

1.2.   Consumables

1.3.   Services

2.       By Technology

2.1.   Genomics

2.2.   Proteomics

2.3.   Cell Biology Technology

2.4.   Lab Supplies

2.5.   Others

3.       By Product

3.1.   Cell Culture Systems & 3D Cell Culture

3.2.   Liquid Chromatography

3.3.   Mass Spectrometry

3.4.   Flow Cytometry

3.5.   Cloning & Genome Engineering

3.6.   Microscopy

3.7.   Next-Generation Sequencing

3.8.   PCR & qPCR

3.9.   Nucleic Acid Preparation

3.10.                  Nucleic Acid Microarray

3.11.                  Sanger Sequencing

3.12.                  Transfection Devices & Gene Delivery Technologies

3.13.                  Nuclear Magnetic Resonance (NMR)

3.14.                  Others

4.       By End User

4.1.   Healthcare

4.1.1.Hospitals

4.1.2.Clinics

4.1.3.Research Laboratories

4.1.4.Diagnostic Laboratories

4.1.5.Physician Office

4.1.6.Community Centres

4.2.   Government & Academic Institutions

4.3.   Biopharmaceutical Company

4.4.   Industrial Applications

4.5.   Others

5.       By Region

5.1.   North America

5.2.   Europe

5.3.   South America

5.4.   Asia-Pacific

5.5.   Middle East and Africa

Key Players Landscape and Outlook

The market is characterized by strong competition as numerous players offer similar products. These players are consistently expanding their product portfolios and introducing new platforms through extensive research and development efforts to maintain their market position. Moreover, major companies are undertaking strategic initiatives such as collaborations, mergers and acquisitions, and new product launches to drive market growth and intensify competition. For example, in February 2022, Agilent Technologies, Inc. formed a partnership with Biosciences, Inc. to integrate the AVITI System with SureSelect target enrichment panels, aiming to provide customers with improved access to genomic tools. This initiative was anticipated to create fresh growth opportunities for the company.

Market Xcel’s reports answer the following questions:

• What is the current and future market size of the product/service in question globally or specific to different countries?

• How are the markets divided into different product/service segments and the market size and growth of each segment?

• What is the market potential of different product segments and their investment case?

• How are the markets predicted to develop in the future and what factors will drive or inhibit growth?

• What is the business environment and regulatory landscape specific to the product/service?

Key Players Operating in Global Life Science Tool Market

·         Becton, Dickinson, and Company

·         Agilent Technologies Inc.

·         Illumina Inc.

·         Thermo Fisher Scientific Inc.

·         F. Hoffmann-La Roche Ltd

·         Bio-Rad Laboratories Inc.

·         Merck KGaA

·         GE Healthcare

·         Bruker Corporation

·         Qiagen NV

·         Danaher Corporation

·         Abbott Laboratories Inc.

·         Shimadzu Corporation

·         Hitachi, Ltd.

·         Oxford Instruments plc

·         Zeiss International

If you can't find what you're searching for or have any custom requirements for Global Life Science Tools Market, you may approach our team at info@marketsandata.com

Table of Contents

1.       Research Methodology

2.       Project Scope & Definitions

3.       Impact of COVID-19 on the Global Life Science Tools Market

4.       Executive Summary

5.       Global Life Science Tools Market Outlook, 2016-2030F

5.1.    Market Size & Forecast

5.1.1.By Value

5.1.2.By Volume

5.2.    By Type

5.2.1.Instruments

5.2.2.Consumables

5.2.3.Services

5.3.    By Technology

5.3.1.Genomics

5.3.2.Proteomics

5.3.3.Cell Biology Technology

5.3.4.Lab Supplies

5.3.5.Others

5.4.    By Product

5.4.1.Cell Culture Systems & 3D Cell Culture

5.4.2.Liquid Chromatography

5.4.3.Mass Spectrometry

5.4.4.Flow Cytometry

5.4.5.Cloning & Genome Engineering

5.4.6.Microscopy

5.4.7.Next Generation Sequencing

5.4.8.PCR & qPCR

5.4.9.Nucleic Acid Preparation

5.4.10.    Nucleic Acid Microarray

5.4.11.    Sanger Sequencing

5.4.12.    Transfection Devices & Gene Delivery Technologies

5.4.13.    Nuclear Magnetic Resonance (NMR)

5.4.14.    Others

5.5.    By End-user

5.5.1.Healthcare

5.5.1.1.              Hospitals

5.5.1.2.              Clinics

5.5.1.3.              Research Laboratories

5.5.1.4.              Diagnostic Laboratories

5.5.1.5.              Physician Office

5.5.1.6.              Community Centres

5.5.2.Government & Academic Institutions

5.5.3.Biopharmaceutical Company

5.5.4.Industrial Applications

5.5.5.Others

5.6.    By Region

5.6.1.North America

5.6.2.Europe

5.6.3.South America

5.6.4.Asia-Pacific

5.6.5.Middle East and Africa

5.7.    By Company Market Share (%), 2022

6.       Global Life Science Tools Market Outlook, By Region, 2016-2030F

6.1.   North America*

6.1.1.By Type

6.1.1.1.              Instruments

6.1.1.2.              Consumables

6.1.1.3.              Services

6.1.2.By Technology

6.1.2.1.              Genomics

6.1.2.2.              Proteomics

6.1.2.3.              Cell Biology Technology

6.1.2.4.              Lab Supplies

6.1.2.5.              Others

6.1.3.By Product

6.1.3.1.              Cell Culture Systems & 3D Cell Culture

6.1.3.2.              Liquid Chromatography

6.1.3.3.              Mass Spectrometry

6.1.3.4.              Flow Cytometry

6.1.3.5.              Cloning & Genome Engineering

6.1.3.6.              Microscopy

6.1.3.7.              Next Generation Sequencing

6.1.3.8.              PCR & qPCR

6.1.3.9.              Nucleic Acid Preparation

6.1.3.10.          Nucleic Acid Microarray

6.1.3.11.          Sanger Sequencing

6.1.3.12.          Transfection Devices & Gene Delivery Technologies

6.1.3.13.          Nuclear Magnetic Resonance (NMR)

6.1.3.14.          Others

6.1.4.By End-user

6.1.4.1.              Healthcare

6.1.4.1.1.                    Hospitals

6.1.4.1.2.                    Clinics

6.1.4.1.3.                    Research Laboratories

6.1.4.1.4.                    Diagnostic Laboratories

6.1.4.1.5.                    Physician Office

6.1.4.1.6.                    Community Centres

6.1.4.2.              Government & Academic Institutions

6.1.4.3.              Biopharmaceutical Company

6.1.4.4.              Industrial Applications

6.1.4.5.              Others

6.1.5.United States*

6.1.5.1.              By Type

6.1.5.1.1.                    Instruments

6.1.5.1.2.                    Consumables

6.1.5.1.3.                    Services

6.1.5.2.              By Technology

6.1.5.2.1.                    Genomics

6.1.5.2.2.                    Proteomics

6.1.5.2.3.                    Cell Biology Technology

6.1.5.2.4.                    Lab Supplies

6.1.5.2.5.                    Others

6.1.5.3.              By Product

6.1.5.3.1.                    Cell Culture Systems & 3D Cell Culture

6.1.5.3.2.                    Liquid Chromatography

6.1.5.3.3.                    Mass Spectrometry

6.1.5.3.4.                    Flow Cytometry

6.1.5.3.5.                    Cloning & Genome Engineering

6.1.5.3.6.                    Microscopy

6.1.5.3.7.                    Next Generation Sequencing

6.1.5.3.8.                    PCR & qPCR

6.1.5.3.9.                    Nucleic Acid Preparation

6.1.5.3.10.                 Nucleic Acid Microarray

6.1.5.3.11.                 Sanger Sequencing

6.1.5.3.12.                 Transfection Devices & Gene Delivery Technologies

6.1.5.3.13.                 Nuclear Magnetic Resonance (NMR)

6.1.5.3.14.                 Others

6.1.5.4.              By End-user

6.1.5.4.1.                    Healthcare

6.1.5.4.1.1.   Hospitals

6.1.5.4.1.2.   Clinics

6.1.5.4.1.3.   Research Laboratories

6.1.5.4.1.4.   Diagnostic Laboratories

6.1.5.4.1.5.   Physician Office

6.1.5.4.1.6.   Community Centres

6.1.5.4.2.                    Government & Academic Institutions

6.1.5.4.3.                    Biopharmaceutical Company

6.1.5.4.4.                    Industrial Applications

6.1.5.4.5.                    Others

6.1.6.Canada

6.1.7.Mexico

*All segments will be provided for all regions and countries covered

6.2.   Europe

6.2.1.Germany

6.2.2.France

6.2.3.Italy

6.2.4.United Kingdom

6.2.5.Russia

6.2.6.Netherlands

6.2.7.Spain

6.2.8.Turkey

6.2.9.Poland

6.3.   South America

6.3.1.Brazil

6.3.2.Mexico

6.3.3.Argentina

6.4.   Asia-Pacific

6.4.1.India

6.4.2.China

6.4.3.Japan

6.4.4.Australia

6.4.5.Vietnam

6.4.6.South Korea

6.4.7.Indonesia

6.4.8.Philippines

6.5.   Middle East & Africa

6.5.1.Saudi Arabia

6.5.2.UAE

6.5.3.South Africa

7.       Market Mapping, 2022

7.1.    By Type

7.2.    By Technology

7.3.    By End-user

7.4.    By Product

7.5.    By Region

8.       Macro Environment and Industry Structure

8.1.    Supply Demand Analysis

8.2.    Import Export Analysis – Volume and Value

8.3.    Supply/Value Chain Analysis

8.4.    PESTEL Analysis

8.4.1.Political Factors

8.4.2.Economic System

8.4.3.Social Implications

8.4.4.Technological Advancements

8.4.5.Environmental Impacts

8.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)

8.5.    Porter’s Five Forces Analysis

8.5.1.Supplier Power

8.5.2.Buyer Power

8.5.3.Substitution Threat

8.5.4.Threat from New Entrant

8.5.5.Competitive Rivalry

9.       Market Dynamics

9.1.    Growth Drivers

9.2.    Growth Inhibitors (Challenges, Restraints)

10.   Regulatory Framework and Innovation

10.1.                     Clinical Trials

10.2.                     Patent Landscape

10.3.                     Regulatory Approvals

10.4.                     Innovations/Emerging Technologies

11.   Key Players Landscape

11.1.                     Competition Matrix of Top Five Market Leaders

11.2.                     Market Revenue Analysis of Top Five Market Leaders (in %, 2022)

11.3.                     Mergers and Acquisitions/Joint Ventures (If Applicable)

11.4.                     SWOT Analysis (For Five Market Players)

11.5.                     Patent Analysis (If Applicable)

12.   Pricing Analysis

13.   Case Studies

14.   Key Players Outlook

14.1.                     Becton, Dickinson, and Company

14.1.1.    Company Details

14.1.2.    Key Management Personnel

14.1.3.    Products & Services

14.1.4.    Financials (As reported)

14.1.5.    Key Market Focus & Geographical Presence

14.1.6.    Recent Developments

14.2.                     Agilent Technologies Inc.

14.3.                     Illumina Inc.

14.4.                     Thermo Fisher Scientific Inc.

14.5.                     F. Hoffmann-La Roche Ltd

14.6.                     Bio-Rad Laboratories Inc.

14.7.                     Merck KGaA

14.8.                     GE Healthcare

14.9.                     Bruker Corporation

14.10.                  Qiagen NV

14.11.                  Danaher Corporation

14.12.                  Abbott Laboratories Inc.

14.13.                  Shimadzu Corporation

14.14.                  Hitachi, Ltd.

14.15.                  Oxford Instruments plc

14.16.                  Zeiss International

*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

15.   Strategic Recommendations

16.   About Us & Disclaimer

List of Figure - Global Life Science Tools Market

Figure 1. Global Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 2. Global Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 3. Global Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 4. Global Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 5. Global Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 6. Global Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 7. Global Life Science Tools Market Share, By Region, In USD Billion, 2016-2030F

Figure 8. North America Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 9. North America Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 10. North America Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 11. North America Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 12. North America Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 13. North America Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 14. North America Life Science Tools Market Share, By Country, In USD Billion, 2016-2030F

Figure 15. United States Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 16. United States Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 17. United States Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 18. United States Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 19. United States Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 20. United States Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 21. Canada Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 22. Canada Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 23. Canada Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 24. Canada Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 25. Canada Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 26. Canada Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 27. Mexico Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 28. Mexico Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 29. Mexico Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 30. Mexico Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 31. Mexico Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 32. Mexico Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 33. Europe Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 34. Europe Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 35. Europe Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 36. Europe Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 37. Europe Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 38. Europe Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 39. Europe Life Science Tools Market Share, By Country, In USD Billion, 2016-2030F

Figure 40. Germany Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 41. Germany Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 42. Germany Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 43. Germany Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 44. Germany Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 45. Germany Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 46. France Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 47. France Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 48. France Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 49. France Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 50. France Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 51. France Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 52. Italy Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 53. Italy Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 54. Italy Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 55. Italy Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 56. Italy Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 57. Italy Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 58. United Kingdom Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 59. United Kingdom Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 60. United Kingdom Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 61. United Kingdom Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 62. United Kingdom Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 63. United Kingdom Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 64. Russia Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 65. Russia Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 66. Russia Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 67. Russia Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 68. Russia Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 69. Russia Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 70. Netherlands Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 71. Netherlands Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 72. Netherlands Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 73. Netherlands Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 74. Netherlands Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 75. Netherlands Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 76. Spain Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 77. Spain Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 78. Spain Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 79. Spain Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 80. Spain Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 81. Spain Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 82. Turkey Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 83. Turkey Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 84. Turkey Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 85. Turkey Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 86. Turkey Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 87. Turkey Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 88. Poland Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 89. Poland Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 90. Poland Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 91. Poland Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 92. Poland Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 93. Poland Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 94. South America Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 95. South America Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 96. South America Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 97. South America Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 98. South America Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 99. South America Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 100. South America Life Science Tools Market Share, By Country, In USD Billion, 2016-2030F

Figure 101. Brazil Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 102. Brazil Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 103. Brazil Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 104. Brazil Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 105. Brazil Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 106. Brazil Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 107. Argentina Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 108. Argentina Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 109. Argentina Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 110. Argentina Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 111. Argentina Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 112. Argentina Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 113. Asia-Pacific Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 114. Asia-Pacific Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 115. Asia-Pacific Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 116. Asia-Pacific Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 117. Asia-Pacific Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 118. Asia-Pacific Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 119. Asia-Pacific Life Science Tools Market Share, By Country, In USD Billion, 2016-2030F

Figure 120. India Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 121. India Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 122. India Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 123. India Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 124. India Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 125. India Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 126. China Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 127. China Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 128. China Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 129. China Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 130. China Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 131. China Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 132. Japan Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 133. Japan Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 134. Japan Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 135. Japan Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 136. Japan Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 137. Japan Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 138. Australia Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 139. Australia Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 140. Australia Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 141. Australia Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 142. Australia Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 143. Australia Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 144. Vietnam Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 145. Vietnam Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 146. Vietnam Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 147. Vietnam Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 148. Vietnam Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 149. Vietnam Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 150. South Korea Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 151. South Korea Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 152. South Korea Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 153. South Korea Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 154. South Korea Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 155. South Korea Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 156. Indonesia Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 157. Indonesia Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 158. Indonesia Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 159. Indonesia Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 160. Indonesia Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 161. Indonesia Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 162. Philippines Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 163. Philippines Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 164. Philippines Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 165. Philippines Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 166. Philippines Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 167. Philippines Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 168. Middle East & Africa Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 169. Middle East & Africa Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 170. Middle East & Africa Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 171. Middle East & Africa Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 172. Middle East & Africa Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 173. Middle East & Africa Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 174. Middle East & Africa Life Science Tools Market Share, By Country, In USD Billion, 2016-2030F

Figure 175. Saudi Arabia Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 176. Saudi Arabia Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 177. Saudi Arabia Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 178. Saudi Arabia Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 179. Saudi Arabia Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 180. Saudi Arabia Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 181. UAE Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 182. UAE Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 183. UAE Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 184. UAE Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 185. UAE Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 186. UAE Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 187. South Africa Life Science Tools Market, By Value, In USD Billion, 2016-2030F

Figure 188. South Africa Life Science Tools Market, By Volume, In Unit Thousand, 2016-2030F

Figure 189. South Africa Life Science Tools Market Share, By Type, In USD Billion, 2016-2030F

Figure 190. South Africa Life Science Tools Market Share, By Technology, In USD Billion, 2016-2030F

Figure 191. South Africa Life Science Tools Market Share, By Product, In USD Billion, 2016-2030F

Figure 192. South Africa Life Science Tools Market Share, By End-user, In USD Billion, 2016-2030F

Figure 193. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2022

Figure 194. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2022

Figure 195. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2022

Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2022

Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2022

List of Table - Global Life Science Tools Market

Table 1. Pricing Analysis of Products from Key Players

Table 2. Competition Matrix of Top 5 Market Leaders

Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)

Table 4. About Us - Region and Countries Where We Have Executed Client Projects

What is the market size and growth rate of the Global Life Science Tools Market?

arrowup
Heart

Japan Artificial Intelligence Market Assessment, Opportunities, and Forecast, FY2017-FY2031F

Japan's Artificial Intelligence market has been witnessing notable progress. The Japan Artificial Intelligence market is estimated to achieve a value of USD 15.84 billion by the fiscal year 2031, showing substantial growth from USD 5.95 billion in FY....Read More

Published on

December 2023

3,300

Heart

Vietnam Commercial Vehicle Market Assessment, Opportunities and Forecast, 2016-2030F

Vietnam Commercial Vehicle Market size was valued at USD 3.07 billion in 2022 which is expected to reach USD 5.84 billion in 2030 with a CAGR of 8.37% for the forecast period between 2023 and 2030. ....Read More

Published on

December 2023

3,300

Heart

Japan Internet of Things Market Assessment, Opportunities and Forecast, FY2017-FY2031

Japan Internet of Things Market size is valued at USD 11.71 billion in FY2023, expected to reach USD 50.08 billion in FY2031 with a CAGR of 19.92% for the forecast period between FY2024 and FY2031.....Read More

Published on

December 2023

3,300

Heart

Japan Ready-To-Eat Food Market Assessment, Opportunities, and Forecast, FY2017-FY2031F

Japan Ready-To-Eat Food Market is expected to witness a CAGR of 4.03% during the forecast period FY2024-FY2031. The market was valued at USD 8.14 billion in FY2023 and is anticipated to reach USD 11.17 billion by FY2031.....Read More

Published on

December 2023

3,300

Purchase Options

USD ($)

arrowdown

i

3,000

i

4,500

i

5,700

i

8,200

Tired of Searching?

Looking for Customization?

Some other doubt?

Need insights from a cohort?

REACH US

    icon_Five
    17, Okhla Industrial Estate Phase 3 Rd, Okhla Phase III, Okhla Industrial Estate, New Delhi, Delhi 110020
    call_Two
    +91 11 42343567
    icon_Six
    info@marketsandata.com
icon_Seven
5741 Cleveland street, Suite 120, VA beach, VA, USA 23462
call_Three
+1 (757) 343-3258
icon_Eight
190 Middle Road, # 14-10 Fortune Centre, Singapore -188979